{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/KOL/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KOL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KOL\",,,,,undefined,":{"symbol":"KOL","market":"US","secType":"STK","nameCN":"VanEck Vectors Coal ETF","latestPrice":94.92,"timestamp":1607979600000,"preClose":94.92,"halted":4,"volume":0,"delay":0,"floatShares":370000,"shares":370000,"eps":0,"marketStatus":"Delisted","change":0,"latestTime":"12-14 16:00:00 EST","open":94.92,"high":94.92,"low":94.92,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1757318400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":94.92,"sharesOutstanding":370000,"nav":95.75227,"aum":35428340.72,"bidAskSpread":0,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KOL\",,,,,undefined,":{"symbol":"KOL","floatShares":370000,"roa":"--","roe":"--","lyrEps":0,"shares":370000,"dividePrice":0,"high":94.92,"amplitude":0,"preClose":94.92,"low":94.92,"week52Low":54.099,"pbRate":"--","week52High":111,"institutionHeld":0,"latestPrice":94.92,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":94.92},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KOL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-12-15","symbol":"KOL","reason":null,"defaultRemindTime":1608042600000,"announcedDate":"2020-12-04","type":"delisting","dateTimestamp":1608008400000},{"market":"US","date":"2020-12-11","symbol":"KOL","amount":3.2432,"defaultRemindTime":1607697000000,"name":"Market Vectors-Coal ETF","payableDate":"2020-12-14","currency":"USD","type":"dividend","dateTimestamp":1607662800000},{"market":"US","date":"2020-04-15","symbol":"KOL","type":"split","dateTimestamp":1586923200000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2019-12-23","symbol":"KOL","amount":0.939,"name":"Market Vectors-Coal ETF","payableDate":"2019-12-24","currency":"USD","type":"dividend","dateTimestamp":1577077200000},{"market":"US","date":"2018-12-20","symbol":"KOL","amount":0.824,"name":"Market Vectors-Coal ETF","currency":"USD","type":"dividend","dateTimestamp":1545282000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KOL\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-20","recordDate":null,"paymentDate":null,"value":0.824,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":null,"value":0.939,"currency":"USD"},{"executeDate":"2020-12-11","recordDate":"2020-12-14","paymentDate":null,"value":3.2432,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KOL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KOL\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2521649694","title":"Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2521649694","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521649694?lang=en_us&edition=fundamental","pubTime":"2025-03-21 04:01","pubTimestamp":1742500860,"startTime":"0","endTime":"0","summary":"TX45 Phase 1b trial interim analysis demonstrated meaningful improvements in both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/20/3046690/0/en/Tectonic-Therapeutic-Announces-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Recent-Business-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOL","TECX","BK4139"],"gpt_icon":0},{"id":"2519383562","title":"Press Release: Lipocine Announces Financial Results for the Full Year Ended December 31, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2519383562","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519383562?lang=en_us&edition=fundamental","pubTime":"2025-03-13 20:00","pubTimestamp":1741867200,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, March 13, 2025 /PRNewswire/ -- Lipocine Inc. , a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced financial results for the year ended December 31, 2024, and provided a corporate update.-- LPCN 1154 is an oral formulation of the neuroactive steroid brexanolone. that Lipocine is developing for the rapid treatment of postpartum. -- Lipocine held a meeting with the U.S. Food and Drug Administration . in the first quarter of 2025 to discuss the NDA submission package for. LPCN 1154  as a treatment for PPD. In the meeting,Lipocine was advised that the FDA believes that, in addition to the. previously completed PK bridge data, a safety and efficacy study of oral. LPCN 1154 in the target population will be required for 505 NDA. submission. Based on observed comparable exposure of LPCN 1154 and the. reference drug in the PK bridge study, the company is initiating a phase. 3 safety a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UAE","KOL","CNS","BK4604","BK4099","GCC","BK4530","BK4585","PPD","BK4007","BK4555","03160","TM","BK4121","LPCN","BK4135","BK4561","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":22,"code":"91000000","status":"200"}]}}